baber/WOPTO huggingface dataset:
Patent ES-2137904-T1 (ES)
Title: Cepillos de dientes.
Inventor: BRADY JOAN
IPC: A46B9/04
Filed: 1996-08-09
Abstract: SE EXPONE UN CEPILLO DE DIENTES QUE TIENE UNA PARTE DE MANGO Y UNA PARTE DE CABEZA, QUE LLEVA, O ESTA ADAPTADA PARA LLEVAR, UNA CONFIGURACION DE CERDAS. EL MANGO TIENE UNA PARTE DE EXTREMO, UNA CINTURA, UNA PARTE DE REBORDE Y UN CUELLO QUE CONECTA EL REBORDE A LA CABEZA. LA CINTURA ES MAS ESTRECHA, AL MENOS VISTA EN PLANTA, QUE LA PARTE DE EXTREMO O REBORDE, Y LA PARTE DE EXTREMO ES PREFERENTEMENTE REDONDEADA. LA CONFIGURACION DE LAS CERDAS PERMITE QUE LOS EXTREMOS DE LAS CERDAS EN CONTACTO CON LOS DIENTES NO SE ENCUENTREN EN UN PLANO PARALELO A LA SUPERFICIE DE LA CABEZA DEL MANGO EN LAS QUE SE ENCUENTRAN EMPOTRADAS LAS CERDAS. EN UNA PRIMERA REALIZACION, LOS EXTREMOS EN CONTACTO CON LOS DIENTES DE AL MENOS UNA PARTE DE LAS CERDAS SE SITUAN EN UNA LINEA CURVA, CUANDO SE OBSERVA EL CEPILLO EN UNA VISTA EN ALZADO. LA LINEA CURVA SE OBTIENE GRACIAS A UNA MEZCLA DE GRUPOS CONCAVOS Y GRUPOS CONVEXOS DE CERDAS. EN UNA SEGUNDA REALIZACION, LA CONFIGURACION DE LAS CERDAS CORRESPONDE AL MENOS A DOSGRUPOS DE CERDAS. LOS EXTREMOS DE LAS CERDAS DEL PRIMER GRUPO EN CONTACTO CON LOS DIENTES, Y LOS DEL SEGUNDO GRUPO IGUALMENTE EN CONTACTO CON LOS DIENTES, SE SITUAN EN LINEAS CURVAS, CUANDO SE OBSERVA EL CEPILLO EN ALZADO. EN UNA TERCERA REALIZACION, LOS EXTREMOS DE LAS CERDAS EN CONTACTO CON LOS DIENTES FORMAN UNA LINEA ONDULADA CONTINUA. EN UNA CUARTA REALIZACION, LOS EXTREMOS DE LAS CERDAS EN CONTACTO CON LOS DIENTES CORRESPONDEN A DOS GRUPOS, UNO SITUADO MAS HACIA ATRAS, EL GRUPO QUE PODRIAMOS DENOMINAR ALMENADO, FORMADO POR FILAS DE CERDAS QUE SE EXTIENDEN TRANSVERSALMENTE, ALTERNANDO LAS FILAS EN CUANTO A SU ALTURA, Y UN GRUPO SITUADO EN LA PARTE DELANTERA, QUE TIENE AL MENOS PARTE DE LAS CERDAS QUE SE EXTIENDEN MAS LEJOS DE LA SUPERFICIE DE LA CABEZA DEL CEPILLO QUE NINGUNA DE LAS CERDAS DEL GRUPO ALMENADO.
Patent CY-1107306-T1 (CY)
Inventor: FREISS BERNARD
IPC: A61K47/40
Filed: 2008-03-13
Abstract: The invention concerns a method for preparing compounds for interaction of an active substance hardly soluble in an aqueous medium with a porous support. The invention is characterized in that it comprises the following steps: (a) mixing the active substance generated by supercritical fluid and the specific amount of porous support; (b) carrying out a molecular diffusion step by contacting in static mode a supercritical fluid with the mixture obtained at step (a) for the time required to improve the dissolution in the aqueous medium of the mixture obtained at step (a); (c) washing the interactive compound obtained at step (b) with a supercritical fluid flow; (d) recuperating the particles of the interactive compound thus formed. The invention also concerns a compound obtainable by said method.
Patent CY-1109441-T1 (CY)
Title: Ενδιαμεσα προϊοντα για την παραγωγη διοξανιου-2-αλκυλκαρβαμικου
Inventor: ABOUABDELLAH AHMED
IPC: A61P29/00
Filed: 2009-09-24
Abstract: Ένωση η οποία αντιστοιχεί στον γενικό χημικό τύπο (ΙΙΙ) στον οποίο το R2 αντιπροσωπεύει μια ομάδα του γενικού χημικού τύπου CHR3CONHR4 στην οποία το R3 αντιπροσωπεύει ένα άτομο υδρογόνου ή μια ομάδα μεθυλίου και το R4 αντιπροσωπεύει ένα άτομο υδρογόνου ή μια ομάδα C1-3- αλκυλίου, C3-5- κυκλοαλκυλ ή (πυριδιν-4-υλ)μεθυλ· και το U αντιπροσωπεύει ένα άτομο υδρογόνου ή μια ομάδα νίτρο-.
Patent CY-1110666-T1 (CY)
Title: Πυραζολοπυριμιδινες καταλληλες για θεραπεια καρκινικων νοσων
Inventor: GUZI TIMOTHY J
IPC: C07D487/04
Filed: 2010-07-08
Abstract: Στις πολλές πραγματοποιήσεις της, η παρούσα εφεύρεση παρέχει μια νέα τάξη ενώσεων pyrazolo[1,5-a]pyrimidine ως αναστολείς κυκλινο-εξαρτώμενων κινασών, μεθόδους παρασκευής τέτοιων ενώσεων, φαρμακευτικές συνθέσεις που περιλαμβάνουν μια ή περισσότερες τέτοιες ενώσεις, μεθόδους παρασκευής φαρμακευτικών συνθέσεων που περιλαμβάνουν μια ή περισσότερες τέτοιες ενώσεις, και μεθόδους θεραπείας, πρόληψης, καταστολής ή βελτίωσης μιας ή περισσοτέρων νόσων που σχετίζονται με τις CDKs χρησιμοποιώντας τέτοιες ενώσεις ή φαρμακευτικές συνθέσεις.
Patent CY-1111227-T1 (CY)
Inventor: SALLARES JUAN
IPC: C07D471/14
Filed: 2010-09-01
Abstract: The present invention concerns a method for manufacturing 1-substituted 1H-imidazo[4,5-c]quinolin-4-amine compounds through their corresponding formamides. The invention also concerns new formamide intermediates.
Patent CY-1113368-T1 (CY)
Title: Αλας π-τολουολο σουλφονικου οξεος της 5-αμινο-3-(2'-ο-ακετυλ-3'-δεοξυ-βητα-d-ριβοφουρανοζυλ)-3η-θειαζολο[4,5-d]πυριμιδινο-2-ονης και μεθοδοι παρασκευης
Inventor: KUCERA DAVID
IPC: A61P35/00
Filed: 2012-09-28
Abstract: Η παρούσα αποκάλυψη αφορά σε άλας π-τολούολο σουλφονικού οξέος της 5-αμινο-3-(2'-O-ακετυλ-3'-δεοξυ-βητα-D-ριβοφουρανοζυλ)-3Η-θειαζολο[4,5-d]πυριμιδιν-2-όνης και χρήση αυτού στη θεραπεία καταστάσεων όπως ιικών μολύνσεων, όγκων και καρκίνων. Επίσης αποκαλυπτόμενη είναι μια μέθοδος παρασκευής του άλατος π-τολούολο σουλφονικού οξέος της 5-αμινο-3-(2'-O-ακετυλ-3'-δεοξυ-βητα-D-ριβοφουρανοζυλ)-3Η-θειαζολο[4,5-d]πυριμιδιν-2-όνης και μέθοδοι για παρασκευή ενώσεων φουρανόζης, οι οποίες είναι χρήσιμα ενδιάμεσα στην παρασκευή φαρμακευτικών ενώσεων, όπως άλατος π-τολούολο σουλφονικού οξέος της 5-αμινο-3-(2'-O-ακετυλ-3'-δεοξυ-βητα-D-ριβοφουρανοζυλ)-3Η-θειαζολο[4,5-d]πυριμιδιν-2-όνης και των παρομοίων.
Patent CY-1113939-T1 (CY)
Inventor: DESARBRE ERIC
IPC: A61P31/04
Filed: 2013-04-22
Abstract: A pharmaceutical composition, comprising a combination of an antibiotically active compound of the formula I:   
with a ²-lactamase inhibitor of one of the formulae II to XIII are active against Gram-negative bacteria, in particular such bacteria which have become resistant against antibiotics such as aztreonam, carumonam and tigemonam. Optionally the compositions may comprise another ²-lactamase inhibitor of one of the formulae II to XIII, particularly of formula V or formula VI.
Patent CY-1117264-T1 (CY)
Inventor: SHERMAN MERRY R
IPC: A61K47/48
Filed: 2015-02-09
Abstract: A naturally occurring or recombinant protein, especially a mutein of porcine urate oxidase (uricase), that is essentially free of large aggregates can be rendered substantially non-immunogenic by conjugation with a sufficiently small number of strands of polymer such that the bioactivity of the protein is essentially retained in the conjugate. Such conjugates are unusually well suited for treatment of chronic conditions because they are less likely to induce the formation of antibodies and/or accelerated clearance than are similar conjugates prepared from protein preparations containing traces of large aggregates.
Patent CY-1118242-T1 (CY)
Title: Ενισχυμενη λεπτη μεμβρανη για ευκαμπτη συσκευασια
Inventor: GATOS KONSTANTINOS G
IPC: B32B27/32
Filed: 2016-11-18
Abstract: Η εφεύρεση παρέχει μία θερμοπλαστική μεμβράνη περιλαμβάνουσα: μία μεμβράνη βάσης, όπου η μεμβράνη βάσης περιλαμβάνει ένα υλικό από εκτατή πολυολεφίνη, περιλαμβάνοντας ένα ή περισσότερα στρώματα˙ και μία πληθώρα εξωθημένων ινωδών στοιχείων˙ όπου τα εξωθημένα ινώδη στοιχεία βρίσκονται επί τουλάχιστον μιας επιφανείας της μεμβράνης βάσης˙ όπου οι εξωθημένες ίνες σχηματίζουν μία ή περισσότερες προεξοχές ως προς το επίπεδο της μεμβράνης βάσης˙ όπου στην τοποθεσία που τοποθετούνται τα ινώδη στοιχεία, επί της μεμβράνης βάσης, μία περιοχή ενός μίγματος υλικών, περιλαμβάνοντας το υλικό μεμβράνης βάσης και το υλικό μεμβράνης, βρίσκεται μεταξύ μιας περιοχής καθαρού υλικού μεμβράνης βάσης και μιας περιοχής καθαρού υλικού μεμβράνης, και όπου το μέσο πάχος της μεμβράνης βάσης είναι μικρότερο του μέσου πάχους της προεξοχής.
Patent CY-1118612-T1 (CY)
Title: Μεθοδοι και χημικες συνθεσεις για την θεραπευτικη αντιμετωπιση των εμμενουσων λοιμωξεων και του καρκινου μεσω αναστολης της οδου προγραμματισμενου κυτταρικου θανατου 1 (pd-1)
Inventor: BARBER DANIEL
IPC: G01N33/574
Filed: 2017-01-16
Abstract: Η παρούσα εφεύρεση προβλέπει μεθόδους και χημικές συνθέσεις για την θεραπευτική αγωγή, πρόληψη ή μείωση των εμμενουσών λοιμώξεων, όπως είναι, π.χ., οι χρόνιες, οι λανθάνουσες και οι βραδείες λοιμώξεις, καθώς και ο καρκίνος. Οι μέθοδοι και χημικές συνθέσεις της εφεύρεσης είναι, εξάλλου χρήσιμες για την ανακούφιση ενός ή περισσοτέρων συμπτωμάτων που σχετίζονται με τέτοιο είδους λοιμώξεις ή καρκίνο.
Patent CY-1123956-T1 (CY)
Title: Φαρμακευτικη συνθεση, περιλαμβανουσα σωματιδια φωσφορικου συνδετικου
Inventor: CHOFFLON LAURENT
IPC: A61K9/20
Filed: 2020-09-03
Abstract: Η παρούσα εφεύρεση αφορά σε φαρμακευτική σύνθεση, περιλαμβάνουσα ορισμένα σωματίδια φωσφορικού συνδετικού που έχουν ορισμένη κατανομή μεγέθους σωματιδίου, μέθοδο για τη βιομηχανική κατασκευή της φαρμακευτικής σύνθεσης και τη χρήση σακχαροσιδηρικού οξυυδροξειδίου που έχει ορισμένη κατανομή μεγέθους σωματιδίου για τη βιομηχανική κατασκευή μιας φαρμακευτικής σύνθεσης.
Patent CY-1123782-T1 (CY)
Title: Μεθοδος για τον κλιματισμο αερα
Inventor: ASCOUGH TOM
IPC: F24F3/14
Filed: 2020-11-26
Abstract: Η παρούσα εφεύρεση αφορά μία μέθοδο για τον κλιματισμό αέρα, όπου η μέθοδος περιλαμβάνει ροή μιας πρώτης ροής αέρα (5) εντός ενός πρώτου συστήματος αερισμού (2) στην πρώτη σερπαντίνα ψύξης (107) που συνδέεται με ένα σύστημα ψύξης (3) με ένα ψυκτικό ρευστό (6) και έναν ψύκτη (109), που χαρακτηρίζεται εκ του ότι η θερμοκρασία της πρώτης ροής αέρα (5), όταν διέρχεται από την πρώτη σερπαντίνα ψύξης (107), είναι χαμηλότερη από τη θερμοκρασία του ψυκτικού ρευστού (6) που ρέει μέσω της πρώτης σερπαντίνας ψύξης (107) και ότι η πρώτη ροή αέρα (5) θερμαίνεται και το ψυκτικό ρευστό (6) που ρέει μέσω της πρώτης σερπαντίνας ψύξης (107) ψύχεται, όταν η πρώτη ροή αέρα (5) διέρχεται μέσω της πρώτης σερπαντίνας ψύξης (107).
Patent CY-1123831-T1 (CY)
Title: Γενετικως τροποποιημενοι ποντικοι υποδοχεα τ κυτταρων
Inventor: MACDONALD LYNN
IPC: C07K14/705
Filed: 2021-02-19
Abstract: Η εφεύρεση παρέχει ένα γενετικώς τροποποιημένο μη-ανθρώπινο ζώο το οποίο περιλαμβάνει στο γονιδίωμα του μη-αναδιατεταγμένους μεταβλητούς γονιδιακούς τόπους υποδοχέα Τ κυττάρων, καθώς επίσης μη-ανθρώπινα έμβρυα, κύτταρα και ιστούς που τους περιλαμβάνουν. Παρέχονται επίσης κατασκευάσματα για δημιουργία του εν λόγω γενετικώς τροποποιημένου μη-ανθρώπινου ζώου και μέθοδοι δημιουργίας τους. Διάφορες μέθοδοι χρήσης του γενετικώς τροποποιημένου μη-ανθρώπινου ζώου επίσης παρέχονται.
Patent HR-P20110764-T1 (HR)
Title: Mitotic kinesin inhibitors and methods of use thereof
Inventor: HANS JEREMY
IPC: C07D413/00
Filed: 2011-10-19
Abstract: This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.
Patent SI-1173153-T1 (SI)
Title: Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
Inventor: PERRY ELIZABETH A
IPC: A61K9/107
Filed: 2000-03-29
Abstract: The invention disclosed herein relates to liquid pharmaceutical compositions for oral administration which contain a drug or active ingredient dissolved in a liquid vehicle or carrier in which the liquid vehicle comprises a glyceride of a long chain fatty acid having from 14 to 22 carbon atoms and a lipophilic surfactant having an HLB of less than 10. Compositions of the invention provide increased drug or active ingredient stability and contain a liquid vehicle which is less reactive with the drug or active ingredient than free fatty acids. In one embodiment, the liquid pharmaceutical compositions contain testosterone undecanoate, a long chain triglyceride, and lauroglycol. The compositions can be orally administered and formulated in soft gel or hard shell capsule form.
Patent SI-2246362-T1 (SI)
Title: Polymer conjugates of mutated neublastin
Inventor: SAH DINAH WEN-YEE
IPC: A61K47/48
Filed: 2004-02-02
Abstract: A dimer comprising a mutated neublastin polypeptide coupled to a polymer is disclosed. Such dimers exhibit prolonged bioavailability and, in preferred embodiments, prolonged biological activity relative to wild-type forms of neublastin.
Patent SI-1923321-T1 (SI)
Title: A method for making a range of injection moulded plastics packaging products that include a bucket and a lid
Inventor: VUILLOT JEAN MARC
IPC: B65D43/02
Filed: 2007-11-20
Abstract: When practicing the present invention, the manufacturer as an initial step, and starting from a given bucket 10, selects the thickness w 30  of a second type lid 30 circumferential region 31 to be less than the thickness w 20  of a first type lid 20 circumferential region 21 whereby the circumferential flange 38 of the second type lid 30 after application on the bucket 10 is more readily manually disengaged from said locking rib 16 by an outward flexural movement of the outermost wall 37. Hence, the second type lid 30 may conveniently be formed as a "flex-off'-type lid fitting the same bucket 10 as the first type lid 20. Making lids of the second type may be by using the same injection mold as used for the first type lid 20, modified by an inlay providing for the reduced wall thickness w 30  and possibly for any minor differences in the design of the peripheral flanges 28, 38, such as the angle ¸ that the upper face A of the flange 28, 38 makes with the vertical, and the dimension a, i.e. the width of the peripheral flange 28, 38.
Patent DE-3650742-T2 (DE)
Inventor: VAN DER LELY CORNELIS
IPC: A01K13/00
Filed: 1986-01-15
Granted: 2000-11-23
Abstract: A device for automatically milking animals, such as cows, comprises a computer controlled milking machine with a milking unit (29) having a support (17) for teat cups (52). The support (17) comprises at least two supporting arms carrying the teat cups (52). These supporting arms are provided with hinging means (53, 55, 56) by means of which the teat cups (52) are movable with respect to the further part of the support (17).
Patent DE-3785315-T2 (DE)
Inventor: MORIMOTO SHIGEO
IPC: C07H17/08
Filed: 1987-12-16
Granted: 1993-07-22
Abstract: Erythromycin A derivativ es represented by the general formula <CHEM> wherein R<1> is a group of the formula R<7>CH2- (wherein R<7> is a hydrogen group or a lower alkyl group) or a group of the formula R<8>O- (wherein R<8> is a lower alkyl group), R<2> is R<8>, a cycloalkyl group, a phenyl group or an aralkyl group, or R<2> and R7 together form an alkylene group, R<3> is a hydrogen atom, a lower alkyl group, a phenyl group or an aralkyl group, or R<3> and R<7> together form an alkylene group, or R<2> and R<3> together form an alkylene group, R<4> is a lower alkyl group, R<5> is a substituted silyl group, and R<6> is a hydrogen atom or R5, are useful as intermediates for the synthesis of antibacterial agents.
Patent DE-3850007-T2 (DE)
Inventor: PERO RONALD W
IPC: A61K33/243
Filed: 1988-08-24
Granted: 1994-09-22
Abstract: The effectiveness of cytostatic and/or cytotoxic drugs and/or radiation in the killing of tumor and/or cancer cells is increased by the administration, along with said drugs and radiation, of an effective activating or inhibiting amount of a compound or agent which activates or inhibits the chromatin-bound enzyme adenosine diphosphate ribosyl transferase (ADPRT) or the administration of an effective intracellular free Ca<+><+>-increasing amount of a compound which induces cellular or oxidative stress or which acts as an inhibitor or antagonist or calmodulin or Ca<+><+>-calmodulin binding. Suitable such compounds or agents include the phenothiazines, antihistamines, butyrophenones, cannabinoids and corticosteriods and particularly metoclopramide when employed in combination with cisplatin.
Patent DE-3871805-T2 (DE)
Inventor: SCHNEIDER A
IPC: B05B7/06
Filed: 1988-08-02
Granted: 1992-12-10
Abstract: A powder spray gun comrpises a tubular housing having ambient air flow passages located in the side wall thereof medially of the opposite ends. A pair of air flow amplifiers are mounted in the housing on opposite sides of the ambient air flow passages and are so oriented that compressed air supplied to the upstream one of these amplifiers, the so called suspension amplifier, is operable to draw ambient air into the outlet end of the suspension amplifier, and compressed air supplied to the downstream amplifier, the so called pattern amplifier, is operable to draw ambient air into the inlet end of the pattern amplifier. The amplifiers are secured within the housing by end caps which are sealingly secured onto the ends of the housing by bayonet pin and slot connectors.
Patent DE-3879175-T2 (DE)
Inventor: NIZAMUDDIN NADIR
IPC: H04Q11/04
Filed: 1988-11-11
Granted: 1996-09-19
Abstract: A key telephone system includes a plurality of ports being linked by port associated bidirectional communication channels which are synchronously switched by transferring bit states between ones of the channels to provide communication paths between the ports as directed by a central processor (7). The ports are also linkable to and via the central processor (7) by port associated message channels. An interface circuit (8) is responsive to the central processor and message channel signals for regulating flow of messages received by the central processor and for effecting single and plural channel distribution of messages from the central processor (7). The message channels permit telephony operating features and functions to be provided either within the central processor or by appropriate apparatus means being connected at any of the ports.
Patent DE-3885438-T2 (DE)
Inventor: BYROM DAVID
IPC: C12P19/04
Filed: 1988-12-09
Granted: 1994-04-28
Abstract: A process for the production of extra-cellular microbial cellulose in which a novel strain of the genus Acetobacter capable of producing extra-cellular microbial cellulose is aerobically cultivated in an aqueous culture medium containing a carbon source and other necessary nutrients. The novel strain is also claimed.
Patent TR-199802326-T2 (TR)
Inventor: MEERKERK PLEUN
IPC: E02D17/20
Filed: 1997-05-14
Abstract: Bir bent, su tutan bir yapi ve benzeri için, uzunlamasina olarak yaklasik prizmatik bir sekle sahip, her biri iki enine yüze (7,8) ve uzunlamasina yönlerine ters yönde paralel olarak uzanan iki uzunlamasina yüze (5, 6) sahip oldugu, çimento ya da benzer bir materyalden yapilmis olan elementleri (1) kapsayan bir kaplama. Her bir elementin bir enine yüzü (7) konkav bir sekilde yapilmisken diger enine yüzü (8), elementlerin çesitli rotasyon konumlarinda birbirlerine enine yüzleri ile dayanmalarini saglayacak sekilde iliskin bir konveks sekilde yapilmistir.
Patent DE-60006712-T2 (DE)
Inventor: KIISKI HARRI
IPC: C05G5/12
Filed: 2000-09-21
Granted: 2004-09-30
Abstract: The invention relates to a process for the preparation of compound fertilizer granules containing at least two of the plant nutrients nitrogen, phosphorous and potassium, said process comprising the steps of: (a) mixing solid fertilizer raw materials and recycled oversize material, (b) crushing the mixture, (c) optionally mixing the crushed mixture with recycled undersize material to provide a solid feed material having a desired composition, (d) feeding the feed material to a melter and introducing hot air into said melter for heating the feed material and for melting a desired portion thereof and keeping said portion in molten state, (e) feeding the partly molten feed material from the melter to a granulator to obtain a granulated product, and (f) cooling and screening the granulated product to obtain dry compound fertilizer granules having a desired size distribution.
Patent DE-60012361-T2 (DE)
Inventor: BINDRA P
IPC: C09B63/00
Filed: 2000-11-13
Granted: 2005-09-01
Abstract: Disclosed is a yellow monoazo pigment which is obtained by diazotization of anthranilic acid, coupling of the diazonium compound with 1-(3'-sulfophenyl)-3-methyl-5-pyrazolone and subsequent laking of the coupling product to a strontium salt. The pigment is characterized by the formula:The new pigment has excellent heat stability and bleed fastness and very high color strength. It is suitable for pigmenting of plastics, inks and coatings, and particularly suitable for pigmenting of plastics.
Patent DE-60014180-T2 (DE)
Inventor: MAES DANIEL H
IPC: A61K8/68
Filed: 2000-04-04
Granted: 2005-10-06
Abstract: The invention relates to a method for improving skin lipid barrier function by applying to the skin a composition comprising effective amounts of a protease inhibitor and a cell differentiation enhancer. The composition is useful in promoting skin lipid barrier repair and maintaining the integrity of the lipid barrier. In this regard, the compositions can be used in the treatment and prevention of dry skin, and associated chrono/proto-aging conditions, in the treatment and prevention of irritation on the skin, in the treatment and prevention of UV-related damage to the skin, and in the enhancement of the retention of self-tanning.
Patent DE-60015824-T2 (DE)
Inventor: AVEN MICHAEL
IPC: A01N25/04
Filed: 2000-01-28
Granted: 2005-03-31
Abstract: The invention relates to an aqueous, concentrated suspension (SC) for crop protection active compounds which comprises     (a) 50 to 400 g/L of at least one crop protection active compound; (b) 50 to 500 g/L of at least one adjuvant, which reduces the surface tension in the spray dilution 40 mN/m or less and does not promote the particle growth of the crop protection active compound; (c) at least one surfactant selected from the groups (c1) and (c2):       (c1) 5 to 75 g/L of one or more non-ionic dispersants,   (c2) 10 to 100 g/Lof one or more anionic dispersants,     (d) up to 150 g/L of one or more anti-freezing agents,   (e) up to 25 g/Lof one or more defoamers,   (f) up to 25 g/L of one or more preservatives, and   (g) 200 to 800 g/L of water, wherein the adjuvant (b) is selected from the group consisting of amine alkoxylates, polyoxyalkylene triglycerides, alkylpolyglycosides, alkenyl succinic anhydride derivatives, polyvinylpyrrolidones, perfluoroalkyl acids derivatives, and mixtures thereof; and to the use of such a concentrate suspension as a pesticide.
Patent DE-60018741-T2 (DE)
Inventor: DE LEEUW JAN
IPC: G05D7/01
Filed: 2000-06-21
Granted: 2006-04-13
Abstract: A constant gas flow regulating device includes an inlet chamber, an outlet chamber and a movable wall that delimits the inlet and outlet chambers from each other. The moveable wall carrics a body comprising an opening that permits communication between the inlet and outlet chambers. An elongate element extends centrally in the opening of the body in the moving direction of the wall. The opening within the body surrounds a portion of the elongate element. In a first position the opening in the movable wall is placed in the vicinity of a first end of the elongate element. The element has a sectional size that gradually increases from the first end to a second end thereof. The size of the opening in the movable wall is larger than the sectional size of the elongate element. A helical spring biases the movable wall towards a first position.
Patent DE-60023834-T2 (DE)
Inventor: BENCZEDI DANIEL
IPC: A23L27/00
Filed: 2000-08-23
Granted: 2006-08-10
Abstract: A process for shaping into a granular form a delivery system for the controlled release of flavor or fragrance compounds. This process includes the steps of preparing a mixture of a continuous phase carrier containing a volatile flavor or fragrance compound or composition finely divided therein and having a low water content. This guarantees that the glass transition temperature of the mixture is the glass transition temperature of the final product. The mixture is then heated within a screw extruder to a temperature of between 90 and 130° C. to form a molten mass, the molten mass is extruded through a die and then chopped as it exits the die. The latter step is performed at a temperature above the glass transition temperature of the carrier.
Patent DE-60023870-T2 (DE)
Inventor: KJELL PATTON
IPC: C07B57/00
Filed: 2000-03-22
Granted: 2006-06-14
Abstract: The present invention provides processes for the preparation of 3-aryloxy-3-arylpropylamines and intermediates thereof using an nucleophilic aromatic displacement in 1,3-dimethyl-2-imidazolidinone or N-methylpyrrolidinone.